Evolutionary action score identifies a subset of TP53 mutated myelodysplastic syndrome with favorable prognosis.
Evolutionary action score identifies a subset of TP53 mutated myelodysplastic syndrome with favorable prognosis. Blood Cancer J. 2021 03 06; 11(3):52.